LONG CHAIN FATTY ACID OXIDATION DISORDERS

Clinical trials for LONG CHAIN FATTY ACID OXIDATION DISORDERS explained in plain language.

Never miss a new study

Get alerted when new LONG CHAIN FATTY ACID OXIDATION DISORDERS trials appear

Sign up with your email to follow new studies for LONG CHAIN FATTY ACID OXIDATION DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental treatment offered to patients with rare metabolic disorder

Disease control AVAILABLE

This program provides access to an experimental medication called triheptanoin for patients with Long Chain Fatty Acid Oxidation Disorders (LC-FAOD). It's for patients who have limited treatment options and cannot participate in clinical trials. The goal is to help manage this ra…

Matched conditions: LONG CHAIN FATTY ACID OXIDATION DISORDERS

Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

LONG CHAIN FATTY ACID OXIDATION DISORDERS

Get alerted when new LONG CHAIN FATTY ACID OXIDATION DISORDERS trials appear

Experimental treatment offered to patients with rare metabolic disorder